dr. Eva Degraeuwe
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent - Eva.Degraeuwe@UGent.be
- ORCID iD
-
0000-0003-2523-3022
Show
Sort by
-
Early Impact of Severe Acute Respiratory Syndrome Coronavirus 2 on Pediatric Clinical Research: A Pan-European and Canadian Snapshot in Time
-
Population pharmacokinetic modeling of lisinopril at steady-state in hypertensive paediatric patients with mild to moderate renal impairement
-
Bayesian population approach to determine lisinopril exposure in hypertensive paediatric patients with mild to moderate renal impairment
-
c4c : NH performance and finance presentation
-
- Conference Paper
- C3
- open access
Potential opportunities for the National Hub Network : gap analysis by the Belgian National Hub
-
How to perform feasibility analysis for the POV studies
-
Paediatric adaptations in the ethical committee and national authority approval process for pharmacological research
-
- Conference Paper
- C3
- open access
Paediatric adaptations for clinical trial site preparation in pharmacological research
-
- Conference Paper
- C3
- open access
How to improve paediatric clinical trial design : a sponsor’s perspective
-
- Conference Paper
- C3
- open access
Investing in sustainable Pediatric European Trial Networks : the value of a young investigator’s community